SALIVARY PROTEINS--MOLECULAR STUDY OF STRUCTURE/FUNCTION
SALIVARY PROTEINS--MOLECULAR STUDY OF STRUCTURE/FUNCTION
批准号:
2130747
负责人:
LIBUSE ANNA BOBEK
金额:
$12.03万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-03-15 至 1997-03-14
关键词:
Candida albicans Escherichia coli antibacterial agents antifungal agents antiinfective agents antiviral agents chimeric proteins chromatography circular dichroism cysteine gene deletion mutation molecular biology molecular cloning molecular site mutant nucleic acid sequence oligonucleotides papain polymerase chain reaction protease inhibitor protein purification protein sequence protein structure protein structure function recombinant DNA saliva site directed mutagenesis
中文摘要
在人类唾液中发现的分子具有许多至关重要的保护功能
英文摘要
Molecules found in human saliva have many protective functions critical
to oral health. The protective qualities of saliva become evident in
individuals with markedly decreased salivary flow (xerostomia or dry
mouth). The long range goal of our research is to design and produce
the individual and/or chimeric human salivary molecules with enhanced
protective functions and to use these as prototypes for development of
artificial salivas. An essential prerequisite for this goal is the
complete understanding of the structure-function relationship of
individual salivary molecules. The availability of mutants provides one
of the most powerful ways to achieve this objective. The use of
molecular biological techniques and recombinant DNA technology proposed
in this application for the production the native, variant (mutant) and
chimeric forms of proteins in the heterologous system (E coli) will
allow us to study the salivary protein's structure and their function at
the molecular level and permit a rational design of salivary
substitutes. Recently, we have obtained recombinant clones encoding
several types of salivary proteins which will enable us to carry out the
proposed studies. Molecules that we will concentrate on are cystatins
(cysteine proteinase inhibitors and anti-bacterial/viral agents) and
histatins (anti-fungal, particularly anti-candidal and anti-bacterial
agents), since they have key protective functions and are amongst the
best characterized salivary molecules on a biochemical basis.
Specifically, we propose to: 1)produce large amounts of biologically
active cystatin and histatin in E coli expression system, 2) construct
mutants of cystatin and histatin which will be used for mapping the
structural domains and/or individual amino acid residues that are
essential for the structural integrity and/or biological function of
these proteins and 3) construct and produce various cystatin/histatin
chimeric proteins with biological activities resembling or exceeding
those of the parent proteins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SALIVARY PROTEINS--MOLECULAR STUDY OF STRUCTURE/FUNCTION
-
批准号:2130748
-
项目类别:
-
资助金额:$12.52万
-
财政年份:1992
-
负责人:LIBUSE ANNA BOBEK
-
依托单位:
SALIVARY PROTEINS--MOLECULAR STUDY OF STRUCTURE/FUNCTION
-
批准号:2130749
-
项目类别:
-
资助金额:$13.01万
-
财政年份:1992
-
负责人:LIBUSE ANNA BOBEK
-
依托单位:
SALIVARY PROTEINS--MOLECULAR STUDY OF STRUCTURE-FUNCTION
-
批准号:3223540
-
项目类别:
-
资助金额:$11.7万
-
财政年份:1992
-
负责人:LIBUSE ANNA BOBEK
-
依托单位:
Novel Antimicrobials: Salivary MUC7 Peptides
-
批准号:6822739
-
项目类别:
-
资助金额:$28.14万
-
财政年份:1992
-
负责人:LIBUSE ANNA BOBEK
-
依托单位:
Novel Antimicrobials: Salivary MUC7 Peptides
-
批准号:7115328
-
项目类别:
-
资助金额:$24.74万
-
财政年份:1992
-
负责人:LIBUSE ANNA BOBEK
-
依托单位:
SALIVARY HISTATIN--THERAPEUTIC AGENT
-
批准号:6516445
-
项目类别:
-
资助金额:$19.53万
-
财政年份:1992
-
负责人:LIBUSE ANNA BOBEK
-
依托单位:
Novel Antimicrobials: Salivary MUC7 Peptides
-
批准号:6920707
-
项目类别:
-
资助金额:$25.33万
-
财政年份:1992
-
负责人:LIBUSE ANNA BOBEK
-
依托单位:
SALIVARY PROTEINS--MOLECULAR STUDY OF STRUCTURE-FUNCTION
-
批准号:3223541
-
项目类别:
-
资助金额:$11.5万
-
财政年份:1992
-
负责人:LIBUSE ANNA BOBEK
-
依托单位:
Novel Antimicrobials: Salivary MUC7 Peptides
-
批准号:7290199
-
项目类别:
-
资助金额:$3.69万
-
财政年份:1992
-
负责人:LIBUSE ANNA BOBEK
-
依托单位:
SALIVARY HISTATIN--THERAPEUTIC AGENT
-
批准号:6175959
-
项目类别:
-
资助金额:$18.92万
-
财政年份:1992
-
负责人:LIBUSE ANNA BOBEK
-
依托单位:
SALIVARY HISTATIN--THERAPEUTIC AGENT
-
批准号:2763466
-
项目类别:
-
资助金额:$18.33万
-
财政年份:1992
-
负责人:LIBUSE ANNA BOBEK
-
依托单位:
SALIVARY HISTATIN--THERAPEUTIC AGENT
-
批准号:6379654
-
项目类别:
-
资助金额:$19.74万
-
财政年份:1992
-
负责人:LIBUSE ANNA BOBEK
-
依托单位:
国内基金
海外基金
登录
查看更多内容
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
-
批准号:32302245
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:潘寒姁
-
依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
-
批准号:82371775
-
项目类别:面上项目
-
资助金额:46万元
-
批准年份:2023
-
负责人:朱慧媛
-
依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
-
批准号:31871817
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:孙爱东
-
依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
-
批准号:81873549
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:刘玉兰
-
依托单位:
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的分子机制
-
批准号:31571933
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:廖小军
-
依托单位:
超高压诱导牛肉中Escherichia coli O157:H7亚致死损伤及其修复研究
-
批准号:31371861
-
项目类别:面上项目
-
资助金额:15.0万元
-
批准年份:2013
-
负责人:江芸
-
依托单位:
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的机制
-
批准号:31371845
-
项目类别:面上项目
-
资助金额:15.0万元
-
批准年份:2013
-
负责人:廖小军
-
依托单位:
高密度二氧化碳致死Escherichia coli的相关蛋白质确证及其结构变化研究
-
批准号:31171774
-
项目类别:面上项目
-
资助金额:66.0万元
-
批准年份:2011
-
负责人:张德权
-
依托单位: